Literature DB >> 20493527

The selective role of myosin VI in lymphoid leukemia cell migration.

Jbireal M Ali Jbireal1, Carina Strell, Bernd Niggemann, Kurt Zänker, Frank Entschladen.   

Abstract

Several myosin isotypes are discussed to be involved in the migration of various cells ranging from tumor cells to leukocytes. We investigated the involvement of myosins II and VI in the lymphoid leukemia cells lines Jurkat, NB4, Dohh-2, and Molt-4 by a three-dimensional, collagen-based migration assay. Down-regulation of myosin VI by siRNA significantly reduced the migratory activity of all cells, whereas the pharmacological inhibition of non-muscle myosin II using blebbistatin had only marginal influence. Therefore, in contrast to differentiated leukocytes and cells from solid tumors, myosin VI plays a crucial role in the migration of leukemic cells.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20493527     DOI: 10.1016/j.leukres.2010.04.018

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  5 in total

1.  Myosin-IIA regulates leukemia engraftment and brain infiltration in a mouse model of acute lymphoblastic leukemia.

Authors:  Eric J Wigton; Scott B Thompson; Robert A Long; Jordan Jacobelli
Journal:  J Leukoc Biol       Date:  2016-01-20       Impact factor: 4.962

2.  Myosin VI in PC12 cells plays important roles in cell migration and proliferation but not in catecholamine secretion.

Authors:  Łukasz Majewski; Magdalena Sobczak; Anna Wasik; Krzysztof Skowronek; Maria Jolanta Rędowicz
Journal:  J Muscle Res Cell Motil       Date:  2011-11-22       Impact factor: 2.698

3.  F-actin polymerization and retrograde flow drive sustained PLCγ1 signaling during T cell activation.

Authors:  Alexander Babich; Shuixing Li; Roddy S O'Connor; Michael C Milone; Bruce D Freedman; Janis K Burkhardt
Journal:  J Cell Biol       Date:  2012-06-04       Impact factor: 10.539

4.  BMP-2 overexpression augments vascular smooth muscle cell motility by upregulating myosin Va via Erk signaling.

Authors:  Ming Zhang; Min Yang; Li-ping Liu; Wayne Bond Lau; Hai Gao; Man-kun Xin; Li-Xiao Su; Jian Wang; Shu-Juan Cheng; Qian Fan; Jing-Hua Liu
Journal:  Oxid Med Cell Longev       Date:  2014-03-20       Impact factor: 6.543

5.  miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6.

Authors:  Chao Lei; Feng Du; Lina Sun; Ting Li; Tingyu Li; Yali Min; Aiying Nie; Xin Wang; Lei Geng; Yuanyuan Lu; Xiaodi Zhao; Yongquan Shi; Daiming Fan
Journal:  Cell Death Dis       Date:  2017-10-12       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.